| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Nosocomial Infection | |||||
| Bacteremia | |||||
| Sepsis | |||||
| Pneumonia | |||||
| Urinary Tract Infection | |||||
| Clostridium Infection | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Clostridium Infections | |||||
| Communicable Diseases | |||||
| Cross Infection | |||||
| Infection | |||||
| Urinary Tract Infections | |||||
| 3 | More general conditions related to this trial | ||||
| Bacterial Infections | |||||
| Gram-Positive Bacterial Infections | |||||
| Inflammation | |||||
| Lung Diseases | |||||
| Pathologic Processes | |||||
| Respiratory Tract Diseases | |||||
| Respiratory Tract Infections | |||||
| Systemic Inflammatory Response Syndrome | |||||
| Urologic Diseases | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Chlorhexidine | |||||
| Chlorhexidine gluconate | |||||
| 5 | More general drug interventions related to this trial | ||||
| Anti-Infective Agents | |||||
| Anti-Infective Agents, Local | |||||
| Dermatologic Agents | |||||
| Disinfectants | |||||
| Pharmacologic Actions | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| John H. Stroger Hospital | |||||
| Sage Products, Inc. | |||||
| Centers for Disease Control and Prevention | |||||
|
